SLC1A5 and cancer: SLC1A5 and SLC3A2/SLC7A5 are also crucial for the metabolism, growth, and proliferation of cancer cells. Inhibiting these transporters can reduce amino acid consumption in TME, thereby increasing amino acid availability.